Exploring how certain proteins behave in brain cells to understand diseases like ALS.
Multifunctional phase sensors for probing and manipulation of intracellular biomolecular condensates
This study is looking at how certain proteins in brain cells might help form important structures that could be linked to diseases like ALS, using new tools to see how these proteins behave in their natural setting, which could help us find better ways to treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10473107 on NIH RePORTER |
What this research studies
This research focuses on understanding how intrinsically-disordered proteins (IDPs) contribute to the formation of biomolecular condensates in brain cells. By developing new sensors, the project aims to study these proteins in their natural environment, which could reveal important insights into their role in diseases such as Amyotrophic Lateral Sclerosis (ALS). The approach involves probing the biophysical properties of these proteins and their interactions, which are crucial for cellular functions. This could lead to a better understanding of the mechanisms behind neurodegenerative diseases and potentially identify new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Amyotrophic Lateral Sclerosis or related neurodegenerative conditions.
Not a fit: Patients with non-neurological conditions or those not diagnosed with ALS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating neurodegenerative diseases like ALS.
How similar studies have performed: While the study of IDPs and their role in neurodegenerative diseases is ongoing, this specific approach using novel sensors is relatively new and has not been extensively tested.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Garcia Quiroz, Felipe — Emory University
- Study coordinator: Garcia Quiroz, Felipe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.